🟢 Noveris Health Sciences is trading 12.12% up today amid biotechnology-sector strength

Noveris Health Sciences is trading at CA$0.18, up +12.12%, mainly supported by biotechnology-sector strength.

• No new company-specific announcement was identified for August 25, 2026.
• The latest material disclosure was an August 20 proposal for up to C$500,000 of convertible debentures, expected to close around August 28, 2026.
• XBI was up 2.06% during regular trading; Nasdaq was up 0.84% and S&P 500 0.34%. Noveris’s USPTO allowance and API work order were announced August 18, not August 25.